Increased Accumulation of Intraneuronal Amyloid β in HIV-Infected Patients

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study

Carr, A. D., Samaras, K., Þórisdóttir, A. S., Kaufmann, G. R., Chisholm, D. J., & Cooper, D. A. (1999) · The Lancet · doi:10.1016/s0140-6736(98)08468-2 · Cited by 1,490 · see citing works

The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice.

Pickford, F., Masliah, E., Britschgi, M., Lucin, K. M., Narasimhan, R., Jaeger, P. A., Small, S., Spencer, B., Rockenstein, E., Levine, B., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33585 · Cited by 1,186 · see citing works

Amyloid Precursor Protein Trafficking, Processing, and Function

Thinakaran, G., & Koo, E. H. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800019200 · Cited by 1,141 · see citing works

Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038 · see citing works

Macroautophagy—a novel β-amyloid peptide-generating pathway activated in Alzheimer's disease

Yu, W. H., Cuervo, A. M., Kumar, A., Peterhoff, C. M., Schmidt, S. D., Lee, J.-H., Mohan, P. S., Mercken, M., Farmery, M. R., Tjernberg, L. O., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200505082 · Cited by 967 · see citing works

Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease

Dickson, D. W., Lee, S. C., Mattiace, L. A., Yen, S.-H. C., & Brosnan, C. F. (1993) · Glia · doi:10.1002/glia.440070113 · Cited by 821 · see citing works

Structural Classification of Toxic Amyloid Oligomers

Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783 · see citing works

Autophagy, amyloidogenesis and Alzheimer disease

Nixon, R. A. (2007) · Journal of Cell Science · doi:10.1242/jcs.019265 · Cited by 749 · see citing works

Globular amyloid β‐peptide ₁₋₄₂ oligomer − a homogenous and stable neuropathological protein in Alzheimer's disease

Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03407.x · Cited by 559 · see citing works

Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

Deshpande, A. M., Mina, E. W., Glabe, C. G., & Busciglio, J. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.1189-06.2006 · Cited by 490 · see citing works

Oxidative stress and the pathogenesis of neurodegenerative disorders.

Reynolds, A. D., Laurie, C., Mosley, R., & Gendelman, H. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(07)82016-2 · Cited by 443 · see citing works

Higher frequency of dementia in older HIV-1 individuals

Valcour, V., Shikuma, C., Shiramizu, B. T., Watters, M. R., Poff, P., Selnes, O. A., Holck, P. S., Grove, J., & Sacktor, N. C. (2004) · Neurology · doi:10.1212/01.wnl.0000134665.58343.8d · Cited by 432 · see citing works

SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Aβ‐Degrading Enzymes in Alzheimer's Disease

Miners, J. S., Baig, S., Palmer, J. C., Palmer, L. E., Kehoe, P. G., & Love, S. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00132.x · Cited by 380 · see citing works

Spectrum of human immunodeficiency virus–associated neocortical damage

Masliah, E., Achim, C. L., Ge, N., DeTeresa, R. M., Terry, R. D., & Wiley, C. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320304 · Cited by 371 · see citing works

Persistence of Neuropsychologic Deficits Despite Long-Term Highly Active Antiretroviral Therapy in Patients With HIV-Related Neurocognitive Impairment

Tozzi, V., Balestra, P., Bellagamba, R., Corpolongo, A., Salvatori, M. F., Comandini, U. V., Vlassi, C., Giulianelli, M., Galgani, S., Antinori, A., et al. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318042e1ee · Cited by 323 · see citing works

The role of amyloid β peptide 42 in Alzheimer's disease

Findeis, M. A. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.006 · Cited by 321 · see citing works

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

Green, D. A., Masliah, E., Vinters, H. V., Beizai, P., Moore, D. J., & Achim, C. L. (2005) · AIDS · doi:10.1097/01.aids.0000161770.06158.5c · Cited by 299 · see citing works

Aggregate‐Prone Proteins Are Cleared from the Cytosol by Autophagy: Therapeutic Implications

Williams, A. J., Jahreiss, L., Sarkar, S., Saiki, S., Menzies, F. M., Ravikumar, B., & Rubinsztein, D. C. (2006) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(06)76003-3 · Cited by 284 · see citing works

Autophagic vacuoles are enriched in amyloid precursor protein-secretase activities: implications for β-amyloid peptide over-production and localization in Alzheimer’s disease

Yu, W. H., Kumar, A., Peterhoff, C., Shapiro Kulnane, L., Uchiyama, Y., Lamb, B. T., Cuervo, A. M., & Nixon, R. A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.05.010 · Cited by 279 · see citing works

Journal of Cell Biology

(2019) · doi:10.1083/jcb · Cited by 257 · see citing works

Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage

Adle‐Biassette, Chrétien, Wingertsmann, Hery, H., Ereau, Scaravilli, Tardieu, & Gray (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00167.x · Cited by 233 · see citing works

Prevalence of Alzheimer plaques in AIDS

Esiri, M. M., Biddolph, S. C., & Morris, C. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.29 · Cited by 224 · see citing works

Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42

Rockenstein, E. M., Mallory, M. E., Mante, M., Sisk, A., & Masliaha, E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1247 · Cited by 221 · see citing works

Differential effects of oligomeric and fibrillar amyloid-β1–42 on astrocyte-mediated inflammation

White, J. A., Manelli, A. M., Holmberg, K. H., Eldik, L. J. V., & LaDu, M. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.013 · Cited by 220 · see citing works

Amyloidogenic processing of β-amyloid precursor protein in intracellular compartments

Vetrivel, K. S., & Thinakaran, G. (2006) · Neurology · doi:10.1212/01.wnl.0000192107.17175.39 · Cited by 217 · see citing works

Prevalence of cognitive disorders differs as a function of age in HIV virus infection

Becker, J. T., López, O. L., Dew, M. A., & Aizenstein, H. J. (2004) · AIDS · doi:10.1097/00002030-200401001-00003 · Cited by 211 · see citing works

Inhibition of Endosomal/Lysosomal Degradation Increases the Infectivity of Human Immunodeficiency Virus

Fredericksen, B. L., Wei, B. L., Yao, J. Q., Luo, T., & García, J. V. (2002) · Journal of Virology · doi:10.1128/jvi.76.22.11440-11446.2002 · Cited by 211 · see citing works

Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains.

Achim, C. L., Heyes, M. P., & Wiley, C. A. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116518 · Cited by 205 · see citing works

Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention

Eckman, C. B., & Eckman, E. A. (2005) · Biochemical Society Transactions · doi:10.1042/bst20051101 · Cited by 201 · see citing works

The γ-Secretase Complex: Membrane-Embedded Proteolytic Ensemble

Wolfe, M. S. (2006) · Biochemistry · doi:10.1021/bi060799c · Cited by 190 · see citing works

HIV-1 Tat inhibits neprilysin and elevates amyloid β

Rempel, H. C., & Pulliam, L. (2005) · AIDS · doi:10.1097/00002030-200501280-00004 · Cited by 186 · see citing works

β ‐Amyloid Degradation and Alzheimer′s Disease

Wang, D.-S., Dickson, D. W., & Malter, J. S. (2006) · BioMed Research International · doi:10.1155/jbb/2006/58406 · Cited by 185 · see citing works

Amyloid-Degrading Enzymes as Therapeutic Targets in Alzheimers Disease

Nalivaeva, N. N., Fisk, L., Belyaev, N. N., & Turner, A. J. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954785 · Cited by 177 · see citing works

Cognitive impairment in older HIV-1-seropositive individuals

Valcour, V., Shikuma, C., Watters, M. R., & Sacktor, N. (2004) · AIDS · doi:10.1097/00002030-200401001-00012 · Cited by 168 · see citing works

Amyloid-β immunisation for Alzheimer's disease

Wisniewski, T., & Konietzko, U. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70170-4 · Cited by 155 · see citing works

A new muscle glycogen storage disease associated with glycogenin-1 deficiency

(2014) · DIAL (Catholic University of Leuven) · doi:10.1002/ana · Cited by 155 · see citing works

Glial Cytokines as Neuropathogenic Factors in HIV Infection

Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S., Marshak, D. R., Nelson, S. J., & Griffin, W. S. T. (1994) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199405000-00003 · Cited by 152 · see citing works

Methamphetamine Inhibits Antigen Processing, Presentation, and Phagocytosis

Tallóczy, Z., Martínez, J., Joset, D., Ray, Y., Gácser, A., Toussi, S., Mizushima, N., Nosanchuk, J., Goldstein, H., Loike, J., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.0040028 · Cited by 147 · see citing works

The APP family of proteins: similarities and differences

Walsh, D. M., Minogue, A. M., Frigerio, C. S., Fadeeva, J. V., Wasco, W., & Selkoe, D. J. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350416 · Cited by 145 · see citing works

The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy

John, J. S. (2007) · Frontiers in bioscience · doi:10.2741/2714 · Cited by 134 · see citing works

Physicochemical characteristics of soluble oligomeric Aβand their pathologic role in Alzheimer's disease

Watson, D., Castaño, E., Kokjohn, T. A., Kuo, Y., Lyubchenko, Y. L., Pinsky, D. J., Connolly, E. S., Esh, C. L., Luehrs, D. C., Stine, W. B., et al. (2005) · Neurological Research · doi:10.1179/016164105x49436 · Cited by 129 · see citing works

β‐Amyloid is a substrate of autophagy in sporadic inclusion body myositis

Lünemann, J. D., Schmidt, J., Schmid, D., Barthel, K., Wrede, A., Dalakas, M. C., & Münz, C. (2007) · Annals of Neurology · doi:10.1002/ana.21115 · Cited by 129 · see citing works

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort

Valcour, V., Shikuma, C. M., Shiramizu, B. T., Watters, M. R., Poff, P., Selnes, O. A., Grove, J., Liu, Y., Abdul-Majid, K.-B., Gartner, S., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.029 · Cited by 127 · see citing works

The role of intracellular amyloid β in Alzheimer's disease

Li, M. C., Chen, L., Lee, D. H. S., Yu, L., & Zhang, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.08.002 · Cited by 116 · see citing works

Aβ-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention

Eckman, E. A., & Eckman, C. B. (2005) · Biochemical Society Transactions · doi:10.1042/bst0331101 · Cited by 116 · see citing works

Accumulation of β‐amyloid precursor protein in HIV encephalitis: Relationship with neuropsychological abnormalities

Giometto, B., An, S., Groves, M., Scaravilli, T., Geddes, J. F., Miller, R., Tavolato, B. F., Beckett, A. A. J., & Scaravilli, F. (1997) · Annals of Neurology · doi:10.1002/ana.410420108 · Cited by 114 · see citing works

A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells

Price, T. O., Uras, F., Banks, W. A., & Nuran Ercal, A. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.030 · Cited by 111 · see citing works

A Closer Look at α-Secretase

Postina, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954668 · Cited by 110 · see citing works

Degradative organelles containing mislocalized α- and β-synuclein proliferate in presenilin-1 null neurons

Wilson, C., Murphy, D. D., Giasson, B. I., Zhang, B., Trojanowski, J. Q., & Lee, V. M. ‐. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403061 · Cited by 106 · see citing works

CELLULAR LOCALIZATION OF MESSENGER RNA ENCODING AMYLOID-BETA-PROTEIN IN NORMAL TISSUE AND IN ALZHEIMER DISEASE

Schmechel, D. E., Goldgaber, D., Burkhart, D., Gilbert, J. R., Gajdusek, D. C., & Roses, A. D. (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00002 · Cited by 105 · see citing works

Specific Compositions of Amyloid-β Peptides as the Determinant of Toxic β-Aggregation

Yoshiike, Y., Chui, D., Akagi, T., Tanaka, N., & Takashima, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212785200 · Cited by 102 · see citing works

Activation of the amyloid cascade in apolipoprotein E4 transgenic mice induces lysosomal activation and neurodegeneration resulting in marked cognitive deficits

Belinson, H., Lev, D., Masliah, E., & Michaelson, D. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5633-07.2008 · Cited by 101 · cited 1× · see citing works

Neurobiology of HIV

Hult, B., Chana, G., Masliah, E., & Everall, I. (2008) · International Review of Psychiatry · doi:10.1080/09540260701862086 · Cited by 101 · see citing works

Quinolinic acid — Iron(II) complexes: Slow autoxidation, but enhanced hydroxyl radical production in the Fenton reaction

Plátenı́k, J., Stopka, P., Vejražka, M., & Štípek, S. (2001) · Free Radical Research · doi:10.1080/10715760100300391 · Cited by 100 · see citing works

Problems of cell death in neurodegeneration and Alzheimer's Disease

Jellinger, K. A., & Stadelmann, C. (2001) · Journal of Alzheimer s Disease · doi:10.3233/jad-2001-3106 · Cited by 99 · see citing works

Diabetes, Insulin Resistance, and Dementia Among HIV-1-Infected Patients

Valcour, V., Shikuma, C. M., Shiramizu, B. T., Williams, A. E., Watters, M. R., Poff, P., Grove, J., Selnes, O. A., & Sacktor, N. C. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200501010-00006 · Cited by 97 · see citing works

Mechanisms of HIV-1 Neurotropism

Dunfee, R. L., Thomas, E., Gorry, P. R., Wang, J., Ancuța, P., & Gabuzda, D. H. (2006) · Current HIV Research · doi:10.2174/157016206777709500 · Cited by 96 · see citing works

Axonal Damage Revealed by Accumulation of β-APP in HIV-positive Individuals without AIDS

An, S., Giometto, B., Groves, M., Miller, R. F., Beckett, A. A. J., Gray, F., Tavolato, B. F., & Scaravilli, F. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199711000-00011 · Cited by 90 · see citing works

Lysosomal pathology associated with ?-synuclein accumulation in transgenic models using an eGFP fusion protein

Rockenstein, E. M., Schwach, G., Ingolić, E., Adame, A., Crews, L. A., Mante, M., Pfragner, R., Schreiner, E., Windisch, M., & Masliah, E. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20446 · Cited by 90 · see citing works

Altered P-Glycoprotein Expression in AIDS Patients with HIV Encephalitis

Langford, D., Grigorian, A., Rosemary, H., Adame, A., Ellis, R. J., Hansen, L. A., & Masliah, E. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.10.1038 · Cited by 89 · see citing works

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice

Spencer, B. J., Marr, R. A., Rockenstein, E. M., Crews, L. A., Adame, A., Potkar, R., Patrick, C., Gage, F. H., Verma, I. M., & Masliah, E. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-109 · Cited by 84 · see citing works

The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications

Russo, C., Venezia, V., Repetto, E., Nizzari, M., Violani, E., Carlo, P., & Schettini, G. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.12.016 · Cited by 80 · see citing works

Cerebral white matter damage in HIV infection demonstrated using β-amyloid precursor protein immunoreactivity

Raja, F., Sherriff, F. E., Morris, C. S., Bridges, L., & Esiri, M. M. (1997) · Acta Neuropathologica · doi:10.1007/s004010050601 · Cited by 78 · see citing works

Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies

Cuello, A. C. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00101.x · Cited by 77 · see citing works

Intracellular A-Beta Amyloid, A Sign for Worse Things to Come?

Echeverrı́a, V., & Cuello, A. C. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:299 · Cited by 75 · see citing works

Challenges in Neuronal Apoptosis

Jellinger, K. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506778249434 · Cited by 74 · see citing works

Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectin

Shin, T. M., Isas, J. M., Hsieh, C.-L., Kayed, R., Glabe, C. G., Langen, R., & Chen, J. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-16 · Cited by 69 · see citing works

γ-Secretase Inhibition and Modulation for Alzheimers Disease

Wolfe, M. S. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954767 · Cited by 66 · see citing works

Accumulation of β-Amyloid Precursor Protein in Axons Correlates with CNS Expression of SIV gp41

Mankowski, J. L., Queen, S. E., Tarwater, P. M., Fox, K., & Perry, V. H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.1.85 · Cited by 65 · see citing works

Vicious Cycles Within the Neuropathophysiologic Mechanisms of Alzheimers Disease

Standridge, J. B. (2006) · Current Alzheimer Research · doi:10.2174/156720506776383068 · Cited by 60 · see citing works

Recent Developments of Structure Based β-Secretase Inhibitors for Alzheimers Disease

Ghosh, A., Kumaragurubaran, N., & Tang, J. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802605775009711 · Cited by 55 · see citing works

Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients

Nebuloni, M., Pellegrinelli, A., Ferri, A., Bonetto, S., Boldorini, R. L., Vago, L., Grassi, M. P., & Costanzi, G. (2001) · AIDS · doi:10.1097/00002030-200103300-00005 · Cited by 55 · see citing works

Aß Immunoreactive Material Is Present in Several Intracellular Compartments in Transfected, Neuronally Differentiated, P19 Cells Expressing the Human Amyloid ß-Protein Precursor

Grant, S. M., Ducatenzeiler, A., Moshe Szyf, A., & Cuello, A. C. (2000) · Journal of Alzheimer s Disease · doi:10.3233/jad-2000-23-403 · Cited by 54 · see citing works

HIV-associated dementia, mitochondrial dysfunction, and oxidative stress

Valcour, V., & Shiramizu, B. (2004) · Mitochondrion · doi:10.1016/j.mito.2004.05.009 · Cited by 52 · see citing works

Tat peptides inhibit neprilysin

Daily, A., Nath, A., & Hersh, L. B. (2006) · Journal of NeuroVirology · doi:10.1080/13550280600760677 · Cited by 52 · see citing works

Role of psychiatric medications as adjunct therapy in the treatment of HIV associated neurocognitive disorders

Ances, B. M., Letendre, S. L., Alexander, T. J., & Ellis, R. J. (2008) · International Review of Psychiatry · doi:10.1080/09540260701877670 · Cited by 52 · see citing works

γ-Secretase: Structure, Function, and Modulation for Alzheimers Disease

Wolfe, M. S. (2008) · Current Topics in Medicinal Chemistry · doi:10.2174/156802608783334024 · Cited by 46 · see citing works

High intracellular concentrations of amyloid‐beta block nuclear translocation of phosphorylated CREB

Arvanitis, D. N., Ducatenzeiler, A., Ou, J.-N., Grodstein, E. I., Andrews, S. D., Tendulkar, S. R., Ribeiro‐da‐Silva, A., Szyf, M., & Cuello, A. C. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04704.x · Cited by 46 · see citing works

Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis

Agrawal, L., Louboutin, J. P., Reyes, B. A. S., Bockstaele, E. J. V., & Strayer, D. S. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302821 · Cited by 44 · see citing works

N-acetylcysteine prevents HIV gp 120-related damage of human cultured astrocytes: correlation with glutamine synthase dysfunction

Visalli, V., Muscoli, C., Sacco, I., Sculco, F., Palma, E., Costa, N., Colica, C., Rotiroti, D., & Mollace, V. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-106 · Cited by 44 · see citing works

Vasculopathy and amyloid beta reactivity in brains of patients with acquired immune deficiency (AIDS).

Iżycka‐Świeszewska, E., Żółtowska, A., Rzepko, R., Gross, M., & Borowska-Lehman, J. (2000) · PubMed · Cited by 39 · see citing works

Identification of a Postendocytic Sorting Sequence in CCR5

Delhaye, M., Gravot, A., Ayinde, D., Niedergang, F., Alizon, M., & Brelot, A. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038422 · Cited by 37 · see citing works

Oxidative Stress Induces Intralysosomal Accumulation of Alzheimer Amyloid β‐Protein in Cultured Neuroblastoma Cells

Zheng, L. P., Roberg, K. B., Jerhammar, F., Marcusson, J. O., & Terman, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.032 · Cited by 35 · see citing works

Beta-Amyloid is a Substrate of Autophagy in Sporadic Inclusion Body Mysositis

Lünemann, J. D., Schmidt, J., Schmid, D., Barthel, K., Wrede, A., Dalakas, M., & Münz, C. (2007) · Aktuelle Neurologie · doi:10.1055/s-2007-987613 · Cited by 31 · see citing works

Regulated Proteolysis of APP and ApoE Receptors

Hoe, H., & Rebeck, G. W. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8017-0 · Cited by 23 · see citing works

Diminished somatostatin gene expression in individuals with HIV and major depressive disorder

Everall, I., Salaria, S., Atkinson, J. H., Young, C., Corbeil, J., Grant, I., Masliah, E., & from the, H. N. R. C. (2006) · Neurology · doi:10.1212/01.wnl.0000244436.04036.a2 · Cited by 20 · see citing works

HIV and CXCR4 in a kiss of autophagic death

Levine, B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29447 · Cited by 19 · see citing works

Tat and amyloid: Multiple interactions

Nath, A., & Hersh, L. B. (2005) · AIDS · doi:10.1097/00002030-200501280-00013 · Cited by 12 · see citing works

Impact of Intracellular β-Amyloid in Transgenic Animals and Cell Models

Cuello, A. C., & Canneva, F. (2008) · Neurodegenerative Diseases · doi:10.1159/000113686 · Cited by 9 · see citing works

Untitled work

Barbero (2014) · doi:10.1016/j · Cited by 1 · see citing works

Single-strand annealing between inverted DNA repeats: Pathway choice, participating proteins, and genome destabilizing consequences

(2018) · Digital Commons@Becker (Washington University School of Medicine) · doi:10.1371/journal

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

Saylor, D. R., Dickens, A. M., Sacktor, N. C., Haughey, N. J., Slusher, B. S., Pletnikov, M. V., Mankowski, J. L., Brown, A. M., Volsky, D. J., & McArthur, J. C. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.27 · Cited by 1,037 · see citing works

Viruses and autophagy

Kudchodkar, S. B., & Levine, B. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.630 · Cited by 276 · see citing works

Current understanding of HIV-associated neurocognitive disorders pathogenesis

Gannon, P. J., Khan, M. Z., & Kolson, D. L. (2011) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32834695fb · Cited by 269 · see citing works

Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer’s disease

Pulliam, L., Sun, B., Mustapić, M., Chawla, S., & Kapogiannis, D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0695-4 · Cited by 246 · see citing works

Pathogenesis of HIV in the Central Nervous System

Valcour, V., Sithinamsuwan, P., Letendre, S. L., & Ances, B. M. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0070-4 · Cited by 210 · see citing works

Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

Nalivaeva, N. N., & Turner, A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14593 · Cited by 172 · see citing works

Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)

Rao, V. R., Ruiz, A. P., & Prasad, V. R. (2014) · AIDS Research and Therapy · doi:10.1186/1742-6405-11-13 · Cited by 161 · see citing works

Tetherin is an exosomal tether

Edgar, J. R., Manna, P. T., Nishimura, S., Banting, G., & Robinson, M. S. (2016) · eLife · doi:10.7554/elife.17180 · Cited by 161 · see citing works

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

Gisslén, M., Krut, J. J., Andréasson, U., Blennow, K., Cinque, P. M., Brew, B. J., Spudich, S., Hagberg, L., Rosengren, L., Price, R. W., et al. (2009) · BMC Neurology · doi:10.1186/1471-2377-9-63 · Cited by 147 · see citing works

Brain Inflammation is a Common Feature of HIV-Infected Patients without HIV Encephalitis or Productive Brain Infection

Tavazzi, E., Morrison, D., Sullivan, P. D., Morgello, S., & Fischer, T. (2014) · Current HIV Research · doi:10.2174/1570162x12666140526114956 · Cited by 133 · see citing works

Tetherin is an exosomal tether.

Edgar, J. R., Manna, P. T., Nishimura, S., Banting, G. S., & Robinson, M. S. (2016) · Apollo (University of Cambridge) · doi:10.17863/cam.27767 · Cited by 126 · see citing works

Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment

Cassol, E., Misra, V., Dutta, A., Morgello, S., & Gabuzda, D. H. (2014) · AIDS · doi:10.1097/qad.0000000000000303 · Cited by 124 · see citing works

Blood neuron-derived exosomes as biomarkers of cognitive impairment in HIV

Sun, B., Dalvi, P., Abadjian, L. R., Tang, N., & Pulliam, L. (2017) · AIDS · doi:10.1097/qad.0000000000001595 · Cited by 123 · see citing works

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

Caniglia, E. C., Cain, L. E., Justice, A. C., Tate, J., Logan, R. W., Sabin, C. A., Winston, A., van Sighem, A., Miró, J. M., Podzamczer, D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000564 · Cited by 121 · see citing works

A Coat of Many Colors: Neuroimmune Crosstalk in Human Immunodeficiency Virus Infection

Kraft-Terry, S. D., Buch, S. J., Fox, H. S., & Gendelman, H. E. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.042 · Cited by 114 · see citing works

Endothelin-1 and its role in the pathogenesis of infectious diseases

Freeman, B. D., Machado, F. S., Tanowitz, H. B., & Desruisseaux, M. S. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.04.021 · Cited by 113 · see citing works

Accelerated epigenetic aging in brain is associated with pre-mortem HIV-associated neurocognitive disorders

Levine, A. J., Quach, A., Moore, D. J., Achim, C. L., Soontornniyomkij, V., Masliah, E., Singer, E. J., Gelman, B. B., Nemanim, N. M., & Horvath, S. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0406-3 · Cited by 112 · see citing works

HIV-associated executive dysfunction in the era of modern antiretroviral therapy: A systematic review and meta-analysis

Walker, K. A., & Brown, G. G. (2017) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2017.1349879 · Cited by 107 · see citing works

Activation of TRPML1 Clears Intraneuronal Aβ in Preclinical Models of HIV Infection

Bae, M. H., Patel, N. P., Xu, H., Lee, M., Tominaga, K., Nath, A., Geiger, J. D., Gorospe, M., Mattson, M. P., & Haughey, N. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0210-14.2014 · Cited by 112 · see citing works

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions

Beardsley, J., & Le, T. P. (2015) · Neurology · doi:10.1212/01.wnl.0000461261.51494.39 · Cited by 102 · see citing works

Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders

Giunta, B. N., Ehrhart, J. C., Obregon, D. F., Lam, L., Le, L., Jin, J., Fernandez, F., Tan, J., & Shytle, R. D. (2011) · Molecular Brain · doi:10.1186/1756-6606-4-23 · Cited by 101 · see citing works

Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers

Soontornniyomkij, V., Moore, D. J., Gouaux, B. D., Soontornniyomkij, B., Tatro, E. T., Umlauf, A., Masliah, E., Levine, A. J., Singer, E. J., Vinters, H. V., et al. (2012) · AIDS · doi:10.1097/qad.0b013e32835a117c · Cited by 100 · see citing works

Mechanisms underlying HIV-associated cognitive impairment and emerging therapies for its management

Ellis, R. J., Marquine, M. J., Kaul, M., Fields, J. A., & Schlachetzki, J. C. M. (2023) · Nature Reviews Neurology · doi:10.1038/s41582-023-00879-y · Cited by 98 · see citing works

Neurocognitive Consequences of HIV Infection in Older Adults: An Evaluation of the “Cortical” Hypothesis

Scott, J. C., Woods, S. P., Carey, C. L., Weber, E., Bondi, M. W., & Grant, I. (2010) · AIDS and Behavior · doi:10.1007/s10461-010-9815-8 · Cited by 89 · see citing works

Differentiating HIV-Associated Neurocognitive Disorders From Alzheimer’s Disease: an Emerging Issue in Geriatric NeuroHIV

Milanini, B., & Valcour, V. (2017) · Current HIV/AIDS Reports · doi:10.1007/s11904-017-0361-0 · Cited by 88 · see citing works

Pathogenesis of age-related HIV neurodegeneration

Mackiewicz, M., Overk, C., Achim, C. L., & Masliah, E. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00728-z · Cited by 83 · see citing works

Granulocyte-macrophage colony-stimulating factor neuroprotective activities in Alzheimer’s disease mice

Kiyota, T., Machhi, J., Lu, Y., Dyavarshetty, B., Nemati, M., Yokoyama, I., Mosley, R. L., & Gendelman, H. E. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.03.009 · Cited by 80 · see citing works

11C-PiB Imaging of Human Immunodeficiency Virus–Associated Neurocognitive Disorder

Ances, B. M. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.761 · Cited by 78 · see citing works

Genetic variation and function of the HIV-1 Tat protein

Spector, C., Mele, A. R., Wigdahl, B. L., & Nonnemacher, M. R. (2019) · Medical Microbiology and Immunology · doi:10.1007/s00430-019-00583-z · Cited by 77 · see citing works

Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy

Bhatia, R., Ryscavage, P., & Taiwo, B. (2011) · Journal of NeuroVirology · doi:10.1007/s13365-011-0073-y · Cited by 78 · see citing works

Role of HIV in Amyloid Metabolism

Ortega, M., & Ances, B. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9546-0 · Cited by 75 · see citing works

Intraindividual variability in HIV infection: Evidence for greater neurocognitive dispersion in older HIV seropositive adults.

Morgan, E. E., Woods, S. P., Delano‐Wood, L., Bondi, M. W., & Grant, I. (2011) · Neuropsychology · doi:10.1037/a0023792 · Cited by 76 · see citing works

Endolysosome involvement in HIV-1 transactivator protein-induced neuronal amyloid beta production

Chen, X., Hui, L., Geiger, N. H., Haughey, N. J., & Geiger, J. D. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.04.015 · Cited by 75 · see citing works

Immunohistochemical Visualization of Amyloid-β Protein Precursor and Amyloid-β in Extra- and Intracellular Compartments in the Human Brain

Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., & Alafuzoff, I. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-091681 · Cited by 71 · see citing works

Multilevel analysis of neuropathogenesis of neurocognitive impairment in HIV

Levine, A. J., Soontornniyomkij, V., Achim, C. L., Masliah, E., Gelman, B. B., Sinsheimer, J. S., Singer, E. J., & Moore, D. J. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0410-7 · Cited by 70 · see citing works

Age-dependent molecular alterations in the autophagy pathway in HIVE patients and in a gp120 tg mouse model: reversal with beclin-1 gene transfer

Fields, J. A., Dumaop, W., Rockenstein, E. M., Mante, M., Spencer, B. J., Grant, I., Ellis, R. J., Letendre, S. L., Patrick, C., Adame, A., et al. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-012-0145-7 · Cited by 69 · see citing works

Aging with HIV infection: A journey to the center of inflammAIDS, immunosenescence and neuroHIV

Nasi, M., Pinti, M., Biasi, S. D., Gibellini, L., Ferraro, D., Mussini, C., & Cossarizza, A. (2014) · Immunology Letters · doi:10.1016/j.imlet.2014.06.012 · Cited by 66 · see citing works

Amyloid beta accumulation in HIV‐1‐infected brain: The role of the blood brain barrier

Andras, I. E., & Toborek, M. J. (2012) · IUBMB Life · doi:10.1002/iub.1106 · Cited by 65 · see citing works

Autophagy in Dementias

Kragh, C. L., Ubhi, K. K., Wyss‐Coray, T., & Masliah, E. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00545.x · Cited by 66 · see citing works

The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era

Chilunda, V., Calderon, T. M., Martínez-Aguado, P., & Berman, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146426 · Cited by 65 · see citing works

Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders

Irollo, E., Luchetta, J., Ho, C.-T., Nash, B., & Meucci, O. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03785-y · Cited by 66 · see citing works

Extracellular vesicles of the blood-brain barrier: Role in the HIV-1 associated amyloid beta pathology

Andras, I. E., Léda, A. R., García-Contreras, M., Bertrand, L., Park, M., Skowrońska, M., & Toborek, M. J. (2016) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2016.12.006 · Cited by 64 · see citing works

Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders

Morgan, E. E., Woods, S. P., Letendre, S. L., Franklin, D. R., Bloss, C. S., Goate, A., Heaton, R. K., Collier, A. C., Marra, C. M., Gelman, B. B., et al. (2013) · Journal of NeuroVirology · doi:10.1007/s13365-013-0152-3 · Cited by 63 · see citing works

Increased CDK5 Expression in HIV Encephalitis Contributes to Neurodegeneration via Tau Phosphorylation and Is Reversed with Roscovitine

Patrick, C., Crews, L. A., Desplats, P., Dumaop, W., Rockenstein, E. M., Achim, C. L., Everall, I., & Masliah, E. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.033 · Cited by 61 · see citing works

Extracellular Vesicles: Roles in Human Viral Infections, Immune-Diagnostic, and Therapeutic Applications

Ipinmoroti, A. O., & Matthews, Q. L. (2020) · Pathogens · doi:10.3390/pathogens9121056 · Cited by 60 · see citing works

Update on HIV-Associated Neurocognitive Disorders

Alfahad, T. B., & Nath, A. (2013) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-013-0387-7 · Cited by 59 · see citing works

Efavirenz Promotes β-Secretase Expression and Increased Aβ1-40,42 via Oxidative Stress and Reduced Microglial Phagocytosis: Implications for HIV Associated Neurocognitive Disorders (HAND)

Brown, L. A. M., Jin, J., Ferrell, D., Sadic, E., Obregon, D. F., Smith, A. J., Tan, J., & Giunta, B. N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095500 · Cited by 59 · see citing works

HIV-1 counteracts an innate restriction by amyloid precursor protein resulting in neurodegeneration

Chai, Q., Jovasevic, V., Malikov, V., Sabo, Y., Morham, S. G., Walsh, D., & Naghavi, M. H. (2017) · Nature Communications · doi:10.1038/s41467-017-01795-8 · Cited by 59 · see citing works

Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders

Rosenthal, J. F., & Tyor, W. R. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00735-0 · Cited by 60 · see citing works

Chronic Inflammation and the Role for Cofactors (Hepatitis C, Drug Abuse, Antiretroviral Drug Toxicity, Aging) in HAND Persistence

Gill, A. J., & Kolson, D. L. (2014) · Current HIV/AIDS Reports · doi:10.1007/s11904-014-0210-3 · Cited by 60 · see citing works

Does HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer’s disease?

Fülöp, T., Witkowski, J. M., Larbi, A., Khalil, A., Herbein, G., & Frost, E. H. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00732-3 · Cited by 59 · see citing works

Role of Neurotrophic Factor Alterations in the Neurodegenerative Process in HIV Associated Neurocognitive Disorders

Fields, J. A., Dumaop, W., Langford, D., Rockenstein, E. M., & Masliah, E. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9520-2 · Cited by 57 · see citing works

HIV-1-induced amyloid beta accumulation in brain endothelial cells is attenuated by simvastatin

Andras, I. E., Eum, S. Y., Huang, W., Zhong, Y., Hennig, B., & Toborek, M. J. (2009) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2009.11.004 · Cited by 56 · see citing works

HIV‐1 infection and neurocognitive impairment in the current era

Tamarit, M. D. P., Álvarez, S., & Muñoz‐Fernández, M. Á. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.711 · Cited by 55 · see citing works

HIV-1-associated inflammation and antiretroviral therapy regulate astrocyte endoplasmic reticulum stress responses

Nooka, S., & Ghorpade, A. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.61 · Cited by 53 · see citing works

The struggle of a good friend getting old: cellular senescence in viral responses and therapy

Kohli, J., Veenstra, I., & Demaria, M. (2021) · The EMBO Reports · doi:10.15252/embr.202052243 · Cited by 52 · see citing works

HIV and Alzheimer’s disease: complex interactions of HIV-Tat with amyloid β peptide and Tau protein

Hategan, A. P., Masliah, E., & Nath, A. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00736-z · Cited by 52 · see citing works

Extracellular Vesicles: A Possible Link between HIV and Alzheimer’s Disease-Like Pathology in HIV Subjects?

Kodidela, S., Gerth, K. A., Haque, S., Gong, Y., Ismael, S., Singh, A. K., Ishrat, T., & Kumar, S. (2019) · Cells · doi:10.3390/cells8090968 · Cited by 50 · see citing works

Methamphetamine Exposure Combined with HIV-1 Disease or gp120 Expression: Comparison of Learning and Executive Functions in Humans and Mice

Kesby, J. P., Heaton, R. K., Young, J. W., Umlauf, A., Woods, S. P., Letendre, S. L., Markou, A., Grant, I., & Semenova, S. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.39 · Cited by 49 · see citing works

The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease

Rubin, L. H., Sundermann, E. E., & Moore, D. J. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0702-9 · Cited by 48 · see citing works

The Human Immunodeficiency Virus Coat Protein gp120 Promotes Forward Trafficking and Surface Clustering of NMDA Receptors in Membrane Microdomains

Xu, H., Bae, M. H., Tovar‐y‐Romo, L. B., Patel, N. P., Bandaru, V. V. R., Pomerantz, D. J., Steiner, J. P., & Haughey, N. J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4072-11.2011 · Cited by 48 · see citing works

HIV-1 Tat-mediated astrocytic amyloidosis involves the HIF-1α/lncRNA BACE1-AS axis

Sil, S., Hu, G., Liao, K., Niu, F., Callen, S. E., Periyasamy, P., Fox, H. S., & Buch, S. J. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000660 · Cited by 45 · see citing works

HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway

Shah, A. B., Vaidya, N. K., Bhat, H. K., & Kumar, A. (2016) · Scientific Reports · doi:10.1038/srep18929 · Cited by 46 · see citing works

HIV in the cART era and the mitochondrial: immune interface in the CNS

Fields, J. A., & Ellis, R. J. (2019) · International review of neurobiology · doi:10.1016/bs.irn.2019.04.003 · Cited by 43 · see citing works

CCR5 antagonist reduces HIV-induced amyloidogenesis, tau pathology, neurodegeneration, and blood-brain barrier alterations in HIV-infected hu-PBL-NSG mice

Bhargavan, B., Woollard, S. M., Mcmillan, J. E. M., & Kanmogne, G. D. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00500-0 · Cited by 43 · see citing works

Combined effects of aging and HIV infection on semantic verbal fluency: A view of the cortical hypothesis through the lens of clustering and switching

Iudicello, J. E., Woods, S. P., Deutsch, R., Grant, I., & Ce, T. H. N. R. (2012) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2011.651103 · Cited by 41 · see citing works

Neurodevelopmental delay in pediatric HIV/AIDS: current perspectives

Pajkrt, D., Blokhuis, C., Caan, M. W. A., & Kootstra, N. A. (2016) · Neurobehavioral HIV Medicine · doi:10.2147/nbhiv.s68954 · Cited by 42 · see citing works

BACE1 Mediates HIV-Associated and Excitotoxic Neuronal Damage Through an APP-Dependent Mechanism

Stern, A. L., Ghura, S., Gannon, P. J., Akay, C., Phan, J. M., Yee, A. C., Vassar, R. J., Gelman, B. B., Kolson, D. L., & Jordan‐Sciutto, K. L. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.1280-17.2018 · Cited by 41 · see citing works

Association of antiretroviral therapy with brain aging changes among HIV-infected adults

Soontornniyomkij, V., Umlauf, A., Soontornniyomkij, B., Gouaux, B. D., Ellis, R. J., Levine, A. J., Moore, D. J., & Letendre, S. L. (2018) · AIDS · doi:10.1097/qad.0000000000001927 · Cited by 41 · see citing works

Methamphetamine and Cannabis: A Tale of Two Drugs and their Effects on HIV, Brain, and Behavior

Saloner, R., Fields, J. A., Marcondes, M. C. G., Iudicello, J. E., von Känel, S., Cherner, M., Letendre, S. L., Kaul, M., & Grant, I. (2020) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-020-09957-0 · Cited by 38 · see citing works

Cognitive deficits associated with combined HIV gp120 expression and chronic methamphetamine exposure in mice

Kesby, J. P., Markou, A., Semenova, S., Grant, I., Ellis, R. J., Letendre, S. L., Achim, C. L., Woods, S. P., Carr, A. M., Letendre, S. L., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.07.014 · Cited by 39 · see citing works

Alterations in brain TREM 2 and Amyloid‐β levels are associated with neurocognitive impairment in HIV ‐infected persons on antiretroviral therapy

Fields, J. A., Spencer, B. J., Swinton, M. K., Qvale, E. M., Marquine, M. J., Alexeeva, A., Gough, S., Soontornniyomkij, B., Valera, E., Masliah, E., et al. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14582 · Cited by 38 · see citing works

HIV Protease Inhibitors Alter Amyloid Precursor Protein Processing via β-Site Amyloid Precursor Protein Cleaving Enzyme-1 Translational Up-Regulation

Gannon, P. J., Akay, C., Yee, A. C., Briand, L. A., Erickson, M. A., Gelman, B. B., Gao, Y., Haughey, N. J., Zink, M. C., Clements, J. E., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.09.006 · Cited by 36 · see citing works

HIV Associated Neurodegenerative Disorders: A New Perspective on the Role of Lipid Rafts in Gp120-Mediated Neurotoxicity

Smith, L. K., Kuhn, T. B., Chen, J. C., & Bamburg, J. R. (2018) · Current HIV Research · doi:10.2174/1570162x16666181003144740 · Cited by 36 · see citing works

β-Amyloid1-42, HIV-1Ba-L (Clade B) Infection and Drugs of Abuse Induced Degeneration in Human Neuronal Cells and Protective Effects of Ashwagandha (Withania somnifera) and Its Constituent Withanolide A

Kurapati, K. R. V., Samikkannu, T., Atluri, V., Kaftanovskaya, E., Yndart, A., & Nair, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112818 · Cited by 37 · see citing works

Effect of Aging and Human Immunodeficiency Virus Infection on Cognitive Abilities

Ciccarelli, N., Fabbiani, M., Baldonero, E., Fanti, I., Cauda, R., Giambenedetto, S. D., & Silveri, M. C. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.04213.x · Cited by 35 · see citing works

Mechanisms and therapeutic potential of interactions between human amyloids and viruses

Michiels, E., Rousseau, F., & Schymkowitz, J. W. H. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03711-8 · Cited by 35 · see citing works

Biotypes of HIV-associated neurocognitive disorders based on viral and immune pathogenesis

Johnson, T. P., & Nath, A. (2022) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000825 · Cited by 35 · see citing works

Brain amyloid in virally suppressed HIV-associated neurocognitive disorder

Howdle, G. C., Quidé, Y., Kassem, M. S., JOHNSON, K., Rae, C. D., Brew, B. J., & Cysique, L. A. (2020) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000739 · Cited by 33 · see citing works

Cerebrospinal Fluid Alzheimer’s Disease Biomarkers in Cerebral Amyloid Angiopathy-Related Inflammation

Renard, D., Wacongne, A., Ayrignac, X., Charif, M., Fourcade, G., Azakri, S., Floch, A. L., Bouly, S., Marelli, C., Arquizan, C., et al. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150621 · Cited by 32 · see citing works

Withaferin A Suppresses Beta Amyloid in APP Expressing Cells: Studies for Tat and Cocaine Associated Neurological Dysfunctions

Tiwari, S., Atluri, V. S. R., Yndart, A., Jayant, R. D., Kaushik, A. K., Geiger, J. D., & Nair, M. N. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00291 · Cited by 32 · see citing works

Antiretroviral Drugs Promote Amyloidogenesis by De-Acidifying Endolysosomes

Liang, H., Ye, Y., Soliman, M. L., Lakpa, K. L., Miller, N., Afghah, Z., Geiger, J. D., & Chen, X. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09862-1 · Cited by 30 · see citing works

Beta amyloid levels in cerebrospinal fluid of HIV-infected people vary by exposure to antiretroviral therapy

Fields, J. A., Swinton, M. K., Soontornniyomkij, B., Carson, A., & Achim, C. L. (2020) · AIDS · doi:10.1097/qad.0000000000002506 · Cited by 30 · see citing works

A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs

Benedetto, I. D., Trunfio, M., Guastamacchia, G., Bonora, S., & Calcagno, A. (2020) · Journal of NeuroVirology · doi:10.1007/s13365-020-00874-9 · Cited by 30 · see citing works

Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?

Ciccarelli, N. (2019) · Infection · doi:10.1007/s15010-019-01373-8 · Cited by 29 · see citing works

HIV‐1 Transactivator Protein Induces ZO‐1 and Neprilysin Dysfunction in Brain Endothelial Cells via the Ras Signaling Pathway

Jiang, W., Huang, W., Chen, Y., Zou, M., Peng, D., & Chen, D. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3160360 · Cited by 28 · see citing works

Role of Inflammasomes in HIV-1 and Drug Abuse Mediated Neuroinflammaging

Sil, S., Niu, F., Chivero, E. T., Singh, S., Periyasamy, P., & Buch, S. J. (2020) · Cells · doi:10.3390/cells9081857 · Cited by 28 · see citing works

Distinguishing Amnestic Mild Cognitive Impairment From HIV-Associated Neurocognitive Disorders

Sundermann, E. E., Bondi, M. W., Campbell, L. M., Gouaux, B. D., Moore, R. C., Soontornniyomkij, V., & Moore, D. J. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa760 · Cited by 25 · see citing works

Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target

Syeda, T., & Cannon, J. R. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22694 · Cited by 28 · see citing works

Role of endolysosomes and inter-organellar signaling in brain disease

Afghah, Z., Chen, X., & Geiger, J. D. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104670 · Cited by 27 · see citing works

Neuropathogenic role of astrocyte‐derived extracellular vesicles in HIV‐associated neurocognitive disorders

Chemparathy, D. T., Ray, S., Ochs, C., Ferguson, N., Gawande, D. Y., Dravid, S. M., Callen, S. E., Sil, S., & Buch, S. J. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12439 · Cited by 26 · see citing works

Alzheimer’s-Like Pathology at the Crossroads of HIV-Associated Neurological Disorders

Chemparthy, D. T., Kannan, M., Gordon, L., Buch, S. J., & Sil, S. (2021) · Vaccines · doi:10.3390/vaccines9080930 · Cited by 26 · see citing works

Expression of HIV gp120 protein increases sensitivity to the rewarding properties of methamphetamine in mice

Kesby, J. P., Hubbard, D. T., Markou, A., & Semenova, S. (2012) · Addiction Biology · doi:10.1111/adb.12023 · Cited by 26 · see citing works

Caprospinol reduces amyloid deposits and improves cognitive function in a rat model of Alzheimer's disease

Lecanu, L., Rammouz, G., McCourty, A., Sidahmed, E., Greeson, J., & Papadopoulos, V. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.033 · Cited by 25 · see citing works

Caffeine Blocks HIV-1 Tat-Induced Amyloid Beta Production and Tau Phosphorylation

Soliman, M. L., Geiger, J. D., & Chen, X. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9707-4 · Cited by 25 · see citing works

Diagnostic and prognostic biomarkers for HAND

McLaurin, K. A., Booze, R. M., & Mactutus, C. F. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-018-0705-6 · Cited by 25 · see citing works

Longitudinal brain atrophy patterns and neuropsychological performance in older adults with HIV-associated neurocognitive disorder compared with early Alzheimer's disease

Milanini, B., Samboju, V., Cobigo, Y., Paul, R. H., Javandel, S., Hellmuth, J. M., Allen, I. E., Miller, B. L., & Valcour, V. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.07.006 · Cited by 27 · see citing works

Genetic, Transcriptomic, and Epigenetic Studies of HIV-Associated Neurocognitive Disorder

Levine, A. J., Panos, S. E., & Horvath, S. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000069 · Cited by 24 · see citing works

Biomarkers of neuronal injury and amyloid metabolism in the cerebrospinal fluid of patients infected with HIV-1 subtypes B and C

de Almeida, S. M., Ribeiro, C. E., Rotta, I., Piovesan, M., Tang, B., Vaida, F., Raboni, S. M., Letendre, S. L., Potter, M., Fernandes, M. S. B., et al. (2017) · Journal of NeuroVirology · doi:10.1007/s13365-017-0591-3 · Cited by 24 · see citing works

Central nervous system (CNS) transcriptomic correlates of human immunodeficiency virus (HIV) brain RNA load in HIV-infected individuals

Sanna, P. P., Fu, Y., Masliah, E., Lefèbvre, C., & Repunte‐Canonigo, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-88052-7 · Cited by 23 · see citing works

Intraneuronal β-Amyloid Accumulation: Aging HIV-1 Human and HIV-1 Transgenic Rat Brain

Li, H., McLaurin, K. A., Mactutus, C. F., Likins, B., Huang, W., Chang, S. L., & Booze, R. M. (2022) · Viruses · doi:10.3390/v14061268 · Cited by 14 · see citing works

Role of HIV in Amyloid Metabolism

Ortega, M., & Ances, B. M. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9546-0 · Cited by 75 · see citing works

The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era

Xu, J., & Ikezu, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9136-0 · Cited by 118 · see citing works

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

Green, D. A., Masliah, E., Vinters, H. V., Beizai, P., Moore, D. J., & Achim, C. L. (2005) · AIDS · doi:10.1097/01.aids.0000161770.06158.5c · Cited by 299 · see citing works

HIV Regulation of Amyloid Beta Production

Pulliam, L. (2009) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-009-9151-9 · Cited by 65 · see citing works